{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-128901","form_type":"8-K","ticker":"OTLK","cik":"0001649989","company_name":"Outlook Therapeutics, Inc.","filed_at":"2024-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.105923+00:00","generated_at":"2026-05-29T02:58:27.634603+00:00","sec_items":["2.05"],"event_type":"other_material","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Outlook Therapeutics cuts workforce by 23% (5 employees) to preserve capital","bullets":["Board approved reduction of 5 employees (~23% of headcount) on Dec 10; effective Dec 13.","Estimated restructuring charges of ~$0.3 million for severance, benefits, and related costs.","Majority of cash payments expected to be substantially complete by end of Q3 2025.","Severance contingent on release of claims; includes COBRA premiums for specified period."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-128901","json":"https://secwatch.observer/filing/0001104659-24-128901.json","markdown":"https://secwatch.observer/filing/0001104659-24-128901.md","text":"https://secwatch.observer/filing/0001104659-24-128901.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649989/000110465924128901/0001104659-24-128901-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649989/000110465924128901/tm2431046d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T02:58:27.634603+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"23e8cd511294b04a19827a208eeb1c662e02a168","claim":"Outlook Therapeutics, Inc. announced a restructuring with charges of approximately $ 0.3 million (5 people, or approximately 23% of the Company’s existing headcount).","evidence_excerpt":"eligibility for severance benefits is contingent upon execution of a general release of claims against the Company. The Company estimates that it will incur approximately $ 0.3 million in restructuring charges in connection with the workforce reduction, consisting of cash-based expenses related to employee severance and notice period payments, benefits and","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1649989/000110465924128901/0001104659-24-128901-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $ 0.3 million"},{"label":"Headcount","value":"5 people, or approximately 23% of the Company’s existing headcount"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}